Literature DB >> 528685

Synonymy of strains of Center for Disease Control group DF-1 with species of Capnocytophaga.

B L Williams, D Hollis, L V Holdeman.   

Abstract

Of eight strains of Center for Disease Control group DF-1 examined, seven had 62 to 87% deoxyribonucleic acid homology with the neotype strain of Capnocytophaga ochracea and one had 72% deoxyribonucleic acid homology with the type strain of C. gingivalis. Deoxyribonucleic acid homology of four strains of Bacteroides ochraceus with the neotype strain of C. ochrecea was 76 to 86%.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 528685      PMCID： PMC273213          DOI： 10.1128/jcm.10.4.550-556.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  [Studies on Fusiformis nucleatus (Knorr) and its pathogenicity for humans and animals].

Authors:  F DE CADORE; L JOUBERT; A R PREVOT; P TARDIEUX
Journal:  Ann Inst Pasteur (Paris)       Date:  1956-12

2.  Determination of the base composition of deoxyribonucleic acid from its thermal denaturation temperature.

Authors:  J MARMUR; P DOTY
Journal:  J Mol Biol       Date:  1962-07       Impact factor: 5.469

3.  Use of a single-strand specific nuclease for analysis of bacterial and plasmid deoxyribonucleic acid homo- and heteroduplexes.

Authors:  J H Crosa; D J Brenner; S Falkow
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

4.  BACTEROIDES ORALIS, PROPOSED NEW SPECIES ISOLATED FROM THE ORAL CAVITY OF MAN.

Authors:  W J LOESCHE; S S SOCRANSKY; R J GIBBONS
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490
  4 in total
  17 in total

1.  Two cases of Capnocytophaga bacteremia, one with endocarditis.

Authors:  M Montejo Baranda; V Acha Arrieta; J Hernandez Almaraz; M Perez Rodriguez; M Antoñana Oraeta; C Aguirre Errasti
Journal:  Can Med Assoc J       Date:  1984-06-01       Impact factor: 8.262

2.  In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.

Authors:  V L Sutter; D Pyeatt; Y Y Kwok
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

3.  Rapid identification of Capnocytophaga isolated from septicemic patients.

Authors:  J E Kristiansen; A Bremmelgaard; H E Busk; O Heltberg; W Frederiksen; T Justesen
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

4.  Antimicrobial susceptibility of Capnocytophaga.

Authors:  S W Forlenza; M G Newman; A L Horikoshi; U Blachman
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

5.  Capnocytophaga spp. contain sulfonolipids that are novel in procaryotes.

Authors:  W Godchaux; E R Leadbetter
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

6.  Septic arthritis involving Capnocytophaga ochracea.

Authors:  R E Winn; W F Chase; P W Lauderdale; F K McCleskey
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

7.  Immunological activities of Capnocytophaga cellular components.

Authors:  Y Murayama; K Muranishi; H Okada; K Kato; S Kotani; H Takada; M Tsujimoto; A Kawasaki; T Ogawa
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Cellular fatty acids of Capnocytophaga species.

Authors:  S B Dees; D E Karr; D Hollis; C W Moss
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

9.  Bacteriology of experimental gingivitis in young adult humans.

Authors:  W E Moore; L V Holdeman; R M Smibert; I J Good; J A Burmeister; K G Palcanis; R R Ranney
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Bacteremia by multidrug-resistant Capnocytophaga sputigena.

Authors:  J L Gomez-Garces; J I Alos; J Sanchez; R Cogollos
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.